Australia markets closed

Xtacy Therapeutics Corp. (TT5.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.0205+0.0055 (+36.67%)
As of 08:03AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Total revenue
21.825
21.825
0
0
101.872
-
Cost of revenue
2.763
2.285
2.667
1.512
0
-
Gross profit
19.062
19.54
-2.667
-1.512
101.872
-
Operating expenses
Selling general and administrative
971.126
856.709
1,242
3,804
673.337
-
Total operating expenses
1,054
939.673
1,375
3,879
696.313
-
Operating income or loss
-1,035
-920.133
-1,378
-3,880
-594.441
-
Interest expense
2.622
-
-
-
-
2.622
Total other income/expenses net
-
401.329
10.867
298.051
-778.598
-
Income before tax
-633.182
-519.936
-1,369
-3,584
-1,375
-
Income from continuing operations
-633.182
-519.936
-1,369
-3,584
-1,375
-
Net income
-633.182
-519.936
-1,369
-3,584
-1,375
-
Net income available to common shareholders
-633.182
-519.936
-1,369
-3,584
-1,375
-
Basic EPS
-0.03
-0.01
-0.05
-0.23
-0.10
-
Diluted EPS
-0.03
-0.01
-0.05
-0.23
-0.10
-
Basic average shares
30,912
43,551
27,153
15,868
13,835
-
Diluted average shares
30,912
43,551
27,153
15,868
13,835
-